AllianceBernstein’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $405K | Buy |
31,120
+8,320
| +36% | +$108K | ﹤0.01% | 2770 |
|
|
2025
Q1 | $241K | Sell |
22,800
-2,610
| -10% | -$27.6K | ﹤0.01% | 2860 |
|
|
2024
Q4 | $431K | Hold |
25,410
| – | – | ﹤0.01% | 2702 |
|
|
2024
Q3 | $590K | Hold |
25,410
| – | – | ﹤0.01% | 2580 |
|
|
2024
Q2 | $619K | Hold |
25,410
| – | – | ﹤0.01% | 2549 |
|
|
2024
Q1 | $858K | Hold |
25,410
| – | – | ﹤0.01% | 2345 |
|
|
2023
Q4 | $801K | Hold |
25,410
| – | – | ﹤0.01% | 2383 |
|
|
2023
Q3 | $649K | Sell |
25,410
-55,660
| -69% | -$1.42M | ﹤0.01% | 2435 |
|
|
2023
Q2 | $2.33M | Buy |
81,070
+58,270
| +256% | +$1.67M | ﹤0.01% | 1821 |
|
|
2023
Q1 | $547K | Hold |
22,800
| – | – | ﹤0.01% | 2524 |
|
|
2022
Q4 | $387K | Hold |
22,800
| – | – | ﹤0.01% | 2768 |
|
|
2022
Q3 | $338K | Sell |
22,800
-3,300
| -13% | -$48.9K | ﹤0.01% | 2808 |
|
|
2022
Q2 | $411K | Hold |
26,100
| – | – | ﹤0.01% | 2758 |
|
|
2022
Q1 | $704K | Hold |
26,100
| – | – | ﹤0.01% | 2536 |
|
|
2021
Q4 | $966K | Hold |
26,100
| – | – | ﹤0.01% | 2474 |
|
|
2021
Q3 | $1.25M | Sell |
26,100
-4,000
| -13% | -$191K | ﹤0.01% | 2408 |
|
|
2021
Q2 | $1.02M | Hold |
30,100
| – | – | ﹤0.01% | 2513 |
|
|
2021
Q1 | $1.24M | Hold |
30,100
| – | – | ﹤0.01% | 2313 |
|
|
2020
Q4 | $1.31M | Buy |
30,100
+14,000
| +87% | +$607K | ﹤0.01% | 2181 |
|
|
2020
Q3 | $691K | Sell |
16,100
-600
| -4% | -$25.8K | ﹤0.01% | 2348 |
|
|
2020
Q2 | $781K | Buy |
+16,700
| New | +$781K | ﹤0.01% | 2327 |
|